Population
Patients with malignant hypertension (MHT)
Design
Review
Authors
Loading...
MHT requires ongoing clinical vigilance despite improved survival; leaves open research into factors sustaining stable incidence.
Malignant hypertension remains a relevant clinical entity with stable incidence, but patient survival has improved significantly with modern antihypertensive and renal replacement therapies.
Januszewicz et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: